JAZZ (Jazz Pharmaceuticals, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by JAZZ officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Patrick Kennedy | Director | A | — | — |
| 2026-08-07 | Seamus Mulligan | Director | A | — | — |
| 2026-08-07 | Laura Hamill | Director | A | — | — |
| 2026-08-07 | Heather Ann McSharry | Director | A | — | — |
| 2026-08-07 | Jennifer E. Cook | Director | A | — | — |
| 2026-08-07 | Mark Douglas Smith | Director | A | — | — |
| 2026-08-07 | Samantha Pearce | EVP, Chief Commercial Officer | F | — | — |
| 2026-08-07 | NORBERT G RIEDEL | Director | A | — | — |
| 2026-08-07 | TED W LOVE | Director | A | — | — |
| 2026-08-07 | BRUCE C COZADD | Director | A | — | — |
| 2026-08-07 | PATRICK G ENRIGHT | Director | A | — | — |
| 2026-08-07 | Rick E Winningham | Director | A | — | — |
| 2026-08-07 | Patrick Kennedy | Director | A | — | — |
| 2026-08-07 | NORBERT G RIEDEL | Director | A | — | — |
| 2026-08-07 | PATRICK G ENRIGHT | Director | A | — | — |
| 2026-08-07 | Samantha Pearce | EVP, Chief Commercial Officer | F | — | — |
| 2026-08-07 | Laura Hamill | Director | A | — | — |
| 2026-08-07 | BRUCE C COZADD | Director | A | — | — |
| 2026-08-07 | Mark Douglas Smith | Director | A | — | — |
| 2026-08-07 | Seamus Mulligan | Director | A | — | — |
| 2026-08-07 | TED W LOVE | Director | A | — | — |
| 2026-08-07 | Jennifer E. Cook | Director | A | — | — |
| 2026-08-07 | Rick E Winningham | Director | A | — | — |
| 2026-08-07 | Heather Ann McSharry | Director | A | — | — |
| 2026-08-05 | BRUCE C COZADD | Director | Sell | — | — |
| 2026-07-06 | BRUCE C COZADD | Director | Sell | — | — |
| 2026-07-02 | Robert Iannone | EVP, Global Head of R&D & CMO | F | — | — |
| 2026-07-02 | Samantha Pearce | EVP, Chief Commercial Officer | F | — | — |
| 2026-07-02 | RENEE D GALA | President & CEO | F | — | — |
| 2026-07-02 | Neena M Patil | EVP & Chief Legal Officer | F | — | — |
| 2026-07-02 | Philip L Johnson | EVP & Chief Financial Officer | F | — | — |
| 2026-06-17 | Mark Douglas Smith | Director | Sell | — | — |
| 2026-06-12 | Neena M Patil | EVP & Chief Legal Officer | Sell | — | — |
| 2026-06-05 | RENEE D GALA | President & CEO | G | — | — |
| 2026-06-03 | BRUCE C COZADD | Director | Sell | — | — |
| 2026-06-01 | Seamus Mulligan | Director | M | — | — |
| 2026-06-01 | Samantha Pearce | EVP, Chief Commercial Officer | MIXED | — | — |
| 2026-06-01 | Neena M Patil | EVP & Chief Legal Officer | Sell | — | — |
| 2026-05-27 | Heather Ann McSharry | Director | Sell | — | — |
| 2026-05-27 | Rick E Winningham | Director | MIXED | — | — |
| 2026-05-05 | BRUCE C COZADD | Director | Sell | — | — |
| 2026-04-03 | BRUCE C COZADD | Director | Sell | — | — |
| 2026-03-09 | Neena M Patil | EVP & Chief Legal Officer | F | — | — |
| 2026-03-09 | RENEE D GALA | President & CEO | F | — | — |
| 2026-03-09 | Patricia Carr | SVP, Chief Accounting Officer | MIXED | — | — |
| 2026-03-09 | Robert Iannone | EVP, Global Head of R&D & CMO | F | — | — |
| 2026-03-09 | Samantha Pearce | EVP, Chief Commercial Officer | F | — | — |
| 2026-03-09 | Mary Elizabeth Henderson | SVP, Technical Operations | F | — | — |
| 2026-03-09 | Philip L Johnson | EVP & Chief Financial Officer | F | — | — |
| 2026-03-09 | BRUCE C COZADD | Director | F | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | — | 9,906,501 | — |
| — | — | 8,577,974 | — |
| — | — | 8,577,974 | — |
| — | 10%+ Owner | 6,919,193 | — |
| — | 10%+ Owner | 3,185,058 | — |
| — | 10%+ Owner | 2,667,050 | — |
| — | 10%+ Owner | 2,657,110 | — |
| — | 10%+ Owner | 2,646,386 | — |
| — | 10%+ Owner | 1,987,942 | — |
| — | Director | 1,403,129 | — |
| — | Director | 1,286,254 | — |
| — | Director | 362,287 | — |
| — | Chief Executive Officer | 358,868 | — |
| — | President | 156,898 | — |
| — | President & CEO | 147,361 | — |
| — | EVP and CFO | 133,387 | — |
| — | EVP & COO | 101,130 | — |
| — | EVP, Global Head of R&D & CMO | 85,107 | — |
| — | Director | 65,978 | — |
| — | President and COO | 60,440 | — |
| — | EVP, Chief Financial Officer | 58,948 | — |
| — | EVP & Chief Financial Officer | 56,431 | — |
| — | Director | 54,355 | — |
| — | EVP & Chief Legal Officer | 48,871 | — |
| — | SVP, Chief Regulatory Officer | 48,544 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the JAZZ quote page; the site-wide leaderboard is on the insider transactions hub.